The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Interim analysis of ABM-1310, a blood-brain barrier-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.

Sarina A.  Piha-Paul

Consulting or Advisory Role - CRC Oncology

Research Funding - Abbvie (Inst); ABM (Inst); Acepodia (Inst); Alkermes (Inst); Aminex (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squib (Inst); Cerulean Pharma (Inst); Chugai Pharma (Inst); Cullinan Oncology (Inst); Curis (Inst); Cyclacel (Inst); Daichi Sanko (Inst); ENB Therapeutics (Inst); Epigenetix (Inst); F-Star Beta Limited (Inst); F-Star Therapeutics, Ltd. (Inst); Five Prime Therapeutics (Inst); Gene Quantum (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Helix BioPharma (Inst); Hengrui Pharmaceutical  (Inst); HiberCell (Inst); Immunomedics (Inst); Incyte (Inst); Jacobio (Inst); Jiangsu Simcere Pharmaceutical Co. Ltd. (Inst); Lilly (Inst); Loxo (Inst); Lytix Biopharma (Inst); MedImmune (Inst); Medivation (Inst); Merck Sharp and Dohme Corp. (Inst); Nectin Therapeutics (Inst); NIH/NCI (Inst); Novartis (Inst); Nurix (Inst); OncoNano Inc (Inst); Pfizer (Inst); Phanes Therapeutics (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Puma Biotechnology (Inst); Purinomia (Inst); RAPT Therapeutics (Inst); Replimune (Inst); Roche/Blueprint (Inst); Seagen (Inst); Shasqi Inc. (Inst); Shasqi Inc. (Inst); Silverback Therapeutics (Inst); Synlogic (Inst); Taiho Oncology (Inst); Tallac Therapeutics, Inc. (Inst); Tesaro (Inst); Theradex (Inst); Theradex (Inst); Toragen Therapeutics, Inc. (Inst); TransThera Biosciences (Inst); Xencor (Inst); ZielBio (Inst)

Macarena Ines  De La Fuente

Consulting or Advisory Role - Abbvie (I); ADC Therapeutics (I); Anheart Therapeutics; Genentech (I); Regeneron (I); Rigel; SERVIER

Research Funding - ADC Therapeutics (I); BeiGene (I); Genentech (I)

Fabio  Iwamoto

Stock and Other Ownership Interests  - Praesidia Biotherapeutics

Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Clearview Cancer Institute; Gennao Bio; Guidepoint Global; KIYATEC; Massive Bio; Medtronic; Merck; MimiVax; Novocure; Praesidia Biotherapeutics; Regeneron; Tocagen; xCures

Speakers' Bureau - Prime Oncology

Research Funding - ABM (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Forma Therapeutics (Inst); Merck (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Pfizer (Inst); Sapience Therapeutics (Inst); Tocagen (Inst)

Travel, Accommodations, Expenses - Oncoceutics

(OPTIONAL) Uncompensated Relationships - Northwest Biotherapeutics

Seema  Nagpal

Consulting or Advisory Role - Biocept; EnClear Therapies; Mirati Therapeutics; Novocure; Nurix; Pyramid Biosciences; SERVIER; Telix Pharmaceuticals

Research Funding - ABM (Inst); Berg Pharma (Inst); Novocure (Inst); SERVIER (Inst); VBI Vaccines (Inst)

Amy M.  Weise

Employment - N/A

Leadership - N/A

Stock and Other Ownership Interests  - N/A

Honoraria - N/A

Consulting or Advisory Role - N/A

Speakers' Bureau - N/A

Research Funding - N/A

Patents, Royalties, Other Intellectual Property - N/A

Expert Testimony - N/A

Travel, Accommodations, Expenses - N/A

Other Relationship - N/A

Jay-Jiguang  Zhu

Stock and Other Ownership Interests  - Abbott Laboratories (I); Abbvie (I); Abbvie (I)

Research Funding - Boston Biomedical (Inst); cns pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Novocure (Inst)

Sunandana  Chandra

Honoraria - Array BioPharma; Bristol Myers Squibb; EMD Serono; Exicure; Novartis; Pfizer; Sanofi/Regeneron

Consulting or Advisory Role - Alkermes; Array BioPharma; Bristol-Myers Squibb; EMD Serono; Exicure; Novartis; Pfizer; Sanofi/Regeneron

Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); exicure (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst)

Chen  Chen

Employment - ABM

Stock and Other Ownership Interests  - ABM

Yali  Fu

Employment - ABM

Stock and Other Ownership Interests  - ABM

Zandong  Yang

Employment - ABM

Stock and Other Ownership Interests  - ABM

Katy K.  Tsai

Consulting or Advisory Role - Bristol-Myers Squibb

Research Funding - ABM (Inst); AstraZeneca (Inst); BioAtla (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Oncosec (Inst); OnKure (Inst); Pfizer (Inst); Replimune (Inst)